FIELD: biotechnology, medicine, pharmacy. SUBSTANCE: invention proposes an agent of the following composition, wt.-%: purified concentrate of mixed pyobacteriophage, 9-15 containing Staphylococcus, Streptococcus, Coli, Proteus, Pseudomonas aeruginosa monophages; 1-% quinozol solution; anhydrous lanolin, 25-35; albumin, 1.8-2.0; vegetable oil (castor, sunflower and others), up to 100. EFFECT: enhanced effectiveness of curative effect, prolonged action, improved medicinal formula. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATMENT OF PATIENT WITH SUPPURATIVE-INFLAMMATORY DISEASES (VARIANTS) | 1997 |
|
RU2144368C1 |
AGENT FOR TREATMENT OF STREPTOCOCCAL ILLNESS | 1995 |
|
RU2103991C1 |
AGENT FOR TREATMENT OF COLI INFECTION-INDUCED DISEASES | 1995 |
|
RU2104015C1 |
BACTERICIDAL PREPARATION | 1990 |
|
RU1704462C |
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
METHOD OF COMPLEX POST-OPERATION TREATMENT OF POST-PERITONITIS PATIENTS | 2008 |
|
RU2371162C1 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
METHOD OF TREATING ABSCESSES IN EXPERIMENT | 2011 |
|
RU2460533C1 |
METHOD FOR TREATING POSTOPERATIONAL ABSCESSES OF ABDOMINAL CAVITY | 2004 |
|
RU2243780C1 |
METHOD OF BACTERIOPHAGE-CONTAINING SUPPOSITORIUM | 2001 |
|
RU2188629C1 |
Authors
Dates
1998-02-27—Published
1995-08-14—Filed